Gene Symbol | Pearson Correlation Coefficient |
---|---|
GPAM | 0.759 |
ETNPPL | 0.73 |
MMP28 | 0.716 |
EYA1 | 0.707 |
PLIN5 | 0.705 |
CABLES1 | 0.699 |
EGFR | 0.699 |
GJB6 | 0.697 |
SPON1 | 0.692 |
ATP13A4 | 0.683 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
FHL2 | -0.449 |
SH3BP1 | -0.42 |
SYNPO2 | -0.413 |
FAM162B | -0.403 |
MUM1L1 | -0.402 |
HS3ST1 | -0.397 |
PLEKHA8P1 | -0.396 |
OSBPL10 | -0.394 |
HRK | -0.394 |
GALNTL5 | -0.393 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of NPFFR1 mRNA | 21298039 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NPFFR1 mRNA | 16483693 |
C006780 | bisphenol A | bisphenol A results in decreased expression of NPFFR1 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of NPFFR1 gene | 28505145 |
C039281 | furan | furan results in decreased expression of NPFFR1 mRNA | 25539665 |
D005839 | Gentamicins | Gentamicins results in decreased expression of NPFFR1 mRNA | 22061828 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of NPFFR1 mRNA | 23557933 |
C025643 | vinclozolin | vinclozolin results in decreased expression of NPFFR1 mRNA | 22570695 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004930 | G-protein coupled receptor activity | - | IBA | 21873635 |
GO:0004930 | G-protein coupled receptor activity | - | NAS | 11024015 |
GO:0008188 | neuropeptide receptor activity | - | NAS | 11024015 |
GO:0042277 | peptide binding | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007186 | G-protein coupled receptor signaling pathway | - | IBA | 21873635 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007218 | neuropeptide signaling pathway | - | IEA | - |
GO:0008150 | biological_process | - | ND | - |
GO:0032870 | cellular response to hormone stimulus | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005887 | integral component of plasma membrane | - | IBA | 21873635 |
KEGG ID | KEGG Term |
---|---|
hsa04080 | Neuroactive ligand-receptor interaction |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | TAS |
R-HSA-375276 | Peptide ligand-binding receptors | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-389397 | Orexin and neuropeptides FF and QRFP bind to their respective receptors | TAS |
R-HSA-416476 | G alpha (q) signalling events | TAS |
R-HSA-500792 | GPCR ligand binding | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
27533886 | Anti-opioid Effects of RFRP-3 on Magnocellular Neuron Activity in Morphine-naive and Morphine-treated Female Rats. (2016 Oct) | Kim JS | Endocrinology |